Chandu Gangadhar Devanpalli

Chandu Gangadhar Devanpalli

Active Director Director DIN 09308822
DIN 09308822 First appointment Sep 2021 Primary industry Travel and Hospitality
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Sep 2021
Shareholding value •••• Premium profile

About Chandu Gangadhar Devanpalli

Data last updated:

Chandu Gangadhar Devanpalli is a Director at Ardent Clinical Research Services Private Limited (since 2021) and Director at St Source Transcript Private Limited (since 2024). The companies operate in Travel and Hospitality and Software. The largest current company by reported revenue is Ardent Clinical Research Services Private Limited at ₹84 Lakh (FY 2025).

DIN 09308822
Primary Designation Director
Industry Travel and Hospitality
First Appointment 06 Sep 2021
Oldest Company Age 5 yrs
Largest company Ardent Clinical Research Services Private Limited · ₹84 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Sep 20212021₹84 Lakh (FY 2025)Active
St Source Transcript Private Limited U72200PN2024PTC236024
Director28 Nov 20242024Active

Board colleagues of Chandu Gangadhar Devanpalli

Directorship timeline

Open interactive timeline →
Ardent Clinical Research Services Private Limited
St Source Transcript Private Limited
Premium access

Shareholding and investment profile for Chandu Gangadhar Devanpalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandu Gangadhar Devanpalli

Chandu Gangadhar Devanpalli currently holds 2 directorships: Ardent Clinical Research Services Private Limited (Director, since 06 Sep 2021, revenue ₹84 Lakh (FY 2025)); St Source Transcript Private Limited (Director, since 28 Nov 2024).

Chandu Gangadhar Devanpalli was first appointed on 06 Sep 2021 as Director at Ardent Clinical Research Services Private Limited. The most recent appointment on record is 28 Nov 2024 at St Source Transcript Private Limited.

The current boards of Chandu Gangadhar Devanpalli's companies include Swati Dattatray Kurandale (Ardent Clinical Research Services Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available